StockData
AXIM Biotechnologies, Inc. logo

AXIM Biotechnologies, Inc. (AXIM) stock

AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2024, quarter ended Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

AXIM Biotechnologies ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

AXIM Biotechnologies's ebitda for the twelve months ending Jun 30, 2024 was -$1.88M. For fiscal 2023 it was -$2.32M. The highest annual figure on record is -$505.73K in fiscal 2014.

Annual ebitda

PeriodPeriod endValueChange
FY2023Dec 31, 2023-$2.32M–
FY2022Dec 31, 2022-$4.23M–
FY2021Dec 31, 2021-$11.86M–
FY2020Dec 31, 2020-$4.93M–
FY2016Dec 31, 2016-$3.76M–
FY2015Dec 31, 2015-$10.05M–
FY2014Dec 31, 2014-$505.73K–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2024Jun 30, 2024-$461.31K–
Q1 FY2024Mar 31, 2024-$293.56K–
Q4 FY2023Dec 31, 2023-$647.19K–
Q3 FY2023Sep 30, 2023-$481.78K–
Q2 FY2023Jun 30, 2023-$590.97K–
Q1 FY2023Mar 31, 2023-$603.88K–
Q4 FY2022Dec 31, 2022-$1.04M–
Q3 FY2022Sep 30, 2022-$1.21M–
Q2 FY2022Jun 30, 2022-$953.88K–
Q1 FY2022Mar 31, 2022-$1.03M–
Q4 FY2021Dec 31, 2021-$5.55M–
Q3 FY2021Sep 30, 2021-$3.27M–
Q2 FY2021Jun 30, 2021-$2.17M–
Q1 FY2021Mar 31, 2021-$861.65K–
Q1 FY2020Mar 31, 2020-$687.89K–
Q3 FY2019Sep 30, 2019-$482.83K–
Q2 FY2019Jun 30, 2019-$583.44K–
Q1 FY2019Mar 31, 2019-$2.29M–
Q3 FY2018Sep 30, 2018-$934.99K–
Q1 FY2017Mar 31, 2017-$475.49K–
Q4 FY2016Dec 31, 2016-$769.38K–
Q3 FY2016Sep 30, 2016-$1.55M–
Q2 FY2016Jun 30, 2016-$490.65K–
Q1 FY2016Mar 31, 2016-$941.34K–
Q4 FY2015Dec 31, 2015-$6.31M–
Q3 FY2015Sep 30, 2015-$1.69M–
Q2 FY2015Jun 30, 2015-$1.56M–
Q1 FY2015Mar 31, 2015-$488.82K–

More AXIM Biotechnologies figures

See a number that looks wrong?